Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-03-11

FDA Approved: ZALEPLON — Supplemental Application (Bionpharma Inc.)

View source ↗

Summary

The FDA approved a supplemental application for zaleplon filed by Bionpharma Inc., enabling continued marketing of the generic sleep medication.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Zaleplon (Zaleplon)

Snippet

SUPPL AP for ZALEPLON (ZALEPLON)